alternatives to glp-1 agonists TrimRX alternative to glp 1 GLP-1
Description
These medications are usually given by subcutaneous injection, with dosing frequencies ranging from daily to weekly

This DPP-4 inhibitor is contraindicated in this patient group on the basis of the respective cardiovascular safety study that has shown a significant increase of hospitalization for heart failure as secondary endpoint in the saxagliptin arm (63, 66)

Collins, L., & Costello, R

During the preparation of this work, the authors used AI tools including Grammarly and Overleaf AI Assist for scientific writing

1 Excess adiposity is a major contributor to BP elevation, with estimates suggesting that obesity causes 65%-78% of primary hypertension cases
